Multiplikator Forward P/S: SANUWAVE (SNWV)
Sanuwave Health Inc (SNWV) is implementing acoustic systems for the healing of diabetic ulcers, leveraging new insurance codes. The expert team is driven by stock options and innovations in regeneration. The strategy is based on expanding B2B sales within US clinics. The expected P/S multiple confirms these trends, while 0.40 reflects the baseline level of the metric, helping to assess market value relative to revenue.
Ringkesan rincian data analitis Sanuwave Health Inc (SNWV)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Sanuwave Health Inc|SNWV - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal sanuwave.com|SNWV - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku SANUWAVE Health|SNWV - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan SANUWAVE|Rasio cepet sanuwave.com
- rincian asil keuangan lan kelipatan valuasi:
SNWV - Penghasilan resik perusahaan|Bathi sing dikarepake Sanuwave Health Inc|SNWV - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi SANUWAVE Health Inc|SNWV - Pangali PEG|Pangali EV/EBITDA SANUWAVE Health, Inc.|SNWV - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan SANUWAVE|SNWV - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sanuwave.com|SNWV - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Sanuwave Health Inc
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:SNWV (SANUWAVE Health, Inc.)
Sanuwave Health Inc (SNWV) innovations in tissue regeneration and its strategic focus on highly qualified personnel drive the potential for future revenues. By analyzing the forward P/S dynamics, an investor can observe the ratio of current market capitalization to expected sales, which allows for an assessment of the fundamental margin of safety and the filtering out of market noise to determine whether the business valuation is justified by upcoming growth or remains susceptible to recession risks.
Karo sapa Sanuwave Health Inc saingan
Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|Outset Medical Corp (OM) - Rasio rega marang prakiraan pendapatan|SmartVest - Rega forward marang dodolan|LNSR (LENSAR Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AVITA Medical Inc. RCEL|Rasio rega marang prakiraan pendapatan Profound Medical (PROF)|Baird Medical Corp (BDMD) - Prakiraan rega marang pendapatan|EDAP TMS SA - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bovie Medical APYX|IceCure Medical Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pulmonx LUNG|TELA Bio (TELA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corp.)|Rasio rega marang prakiraan pendapatan sensushealthcare.com|Multiplikator forward rega marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan inspira-technologies.com IINN|Rasio rega marang pendapatan sing dikarepake ICU (SeaStar Medical Holding Corp.)|IRIX: Multiplikator forward rega marang pendapatan|ibs.inc - Rasio rega marang pendapatan sing dikarepake|XAIR: Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan PFSA (Profusa Inc.)|Multiplikator forward rega marang pendapatan SSKN|Rasio rega marang prakiraan pendapatan GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)
